P76.03 Efficacy and Safety of Capmatinib Plus Nivolumab in Pretreated Patients with EGFR Wild-Type Non–Small Cell Lung Cancer

Authors :: M. Cobo
N. Liu
R. Tiedt
V. Minotti
J. Vazquez
Brett G.M. Hughes
Alessandra Bearz
Michael Boyer
Denis Moro-Sibilot
Enriqueta Felip
X. Le
Michael Mark
L. Hao
Ying Cheng
B. Massuti
Juergen Wolf
Daniel Shao Weng Tan
Source :: Journal of Thoracic Oncology. 16:S585-S586
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Pulmonary and Respiratory Medicine
Capmatinib
Oncology
business.industry
Cancer research
Wild type
Medicine
Non small cell
Nivolumab
business
Lung cancer
medicine.disease

Tools